Gateway 2012: I Holland Limited - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Gateway 2012: I Holland Limited



Your online Gateway to I Holland Limited in 2012

Meadow Lane, Long Eaton,
Nottingham, NG10 2GD, England
Telephone:+44 (0) 115 972 6153
Fax: +44 (0) 115 973 1789
www.iholland.co.uk

I Holland Americas
1684 Target Court, Suite 3
Fort Myers, FL 33905
web: www.iholland-americas.com
Telephone: 1-800-420-2991
Email: ihollandtools@comcast.net

About I Holland Limited

More than six decades of research, development and investment has established I Holland as the leading supplier of punches and dies to producers of tablets in a variety of sectors.



Our Commitment to understanding the science behind tabletting has led to the development of innovative materials, bespoke tablet/tool design and established quality assurance technology, all supported by unrivalled customer service.

I Holland is now the sole distributor of OTEC DF (Drag Finishing) machines and consumables in North America.

The automated polisher is just one part of our PharmaCare™ 7-Step Process, developed as a professional maintenance and storage program for punches & dies, enabling you to get the most out of your investment and increase your productivity.

See demonstrations of our PharmaCare™ equipment at Interphex booth#3532 or our newly opened Technical Support Center in Fort Myers, Florida.

New Products
and Releases
New Whitepapers

iHolland Tablet Tooling

Case Study ‘Pfizer Anti-Stick Trials
I Holland Multi Tip Tooling Research Document ‘Atomic Force Microscopy Anti-Sticking Research’
I Holland PharmaCareTM 7-Step Process  

 

 

For more information:

info@iholland.co.uk

 



ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
24%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
10%
All of the above.
44%
No government involvement in patient treatment or drug development.
10%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?

Click here